OpenVSafe by OpenVAERS
Search V-safe

4NE-31778-38702

2 vaccinations 3 coded responses 16 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
852 / AZ
Registered
2021-02-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-01
    Registered in v-safe
  3. 2021-02-01
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-02-11
    Dose 2 — Pfizer-BioNTech
  6. 2021-02-11
    Health check-in — day 0, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work
    Adult check-in
  8. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  9. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  13. 2021-02-18
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  14. 2021-02-26
    Survey response — day 14, dose 2
    MedDRA: Livedo reticularis, Poor peripheral circulation, Pre-existing disease — Feeling: Good
    Free text: Poor circulation. Presents in hands and feet. Skin is very mottled, with one episode of what Im pretty certain is Reynauds Phenomenon
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-14
    Survey response — day 28, dose 2
    MedDRA: Poor peripheral circulation, Temperature intolerance — Feeling: Good
    Free text: Lack of circulation to my hands and feet, worse with cold temperatures or holding something cold. Consistent with Reynauds phenomenon if that describes things better....
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-19
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  18. 2021-03-25
    Survey response — day 42, dose 2
    MedDRA: Coagulopathy, Fatigue, Hypoaesthesia, Office visit, Raynaud's phenomenon — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Diagnosed with Reynauds phenomenon, my doctor is running all sorts of lab work for clotting issues, numbness, extreme fatigue · Healthcare visit (other): In person with PCP
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-25
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-05-15
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  21. 2022-03-08

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Pfizer-BioNTech
22021-02-11Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 4 — day 14, dose 2

2021-02-26

Symptoms: Poor circulation. Presents in hands and feet. Skin is very mottled, with one episode of what Im pretty certain is Reynauds Phenomenon

Release 5 — day 28, dose 2

2021-03-14

Symptoms: Lack of circulation to my hands and feet, worse with cold temperatures or holding something cold. Consistent with Reynauds phenomenon if that describes things better....

Release 6 — day 42, dose 2

2021-03-25

Symptoms: Diagnosed with Reynauds phenomenon, my doctor is running all sorts of lab work for clotting issues, numbness, extreme fatigue
Healthcare visit (other): In person with PCP

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDCoagulopathy ✓ · ✓
SDFatigue ✓ ✓ ✓
SDHypoaesthesia ✓ ✓ ✓
SDLivedo reticularis ✓ ✓ ✓
SDOffice visit ✓ · ✓
SDPoor peripheral circulation ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRaynaud's phenomenon ✓ ✓ ✓
SDTemperature intolerance ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release